| VRTX | Vertex Pharmaceuticals Inc | $111.13B | +82170841.21% |
| VRNA | Verona Pharma Plc | $77.75B | +57489623.61% |
| REGN | Regeneron Pharmaceuticals Inc | $65.28B | +48274360.35% |
| ARGX | Argen X SE | $54.32B | +40168804.04% |
| ALNY | Alnylam Pharmaceuticals Inc | $39.13B | +28937468.90% |
| ONC | BeiGene Ltd | $34.73B | +25682621.95% |
| RVMD | Revolution Medicines Inc | $30.63B | +22647042.88% |
| RPRX | Royalty Pharma plc - Class A | $23.57B | +17431184.46% |
| BNTX | BioNTech SE | $23.52B | +17390278.49% |
| INSM | Insmed Inc | $23.04B | +17035115.20% |
| ROIV | Roivant Sciences Ltd | $21.31B | +15755953.76% |
| INCY | Incyte Corp | $19.46B | +14391648.55% |
| MRNA | Moderna Inc | $18.90B | +13976224.44% |
| GMAB | Genmab | $17.06B | +12611667.21% |
| ASND | Ascendis Pharma A/S | $15.18B | +11224214.89% |
| JAZZ | Jazz Pharmaceuticals plc | $14.70B | +10873372.26% |
| SMMT | Summit Therapeutics Inc | $13.47B | +9961417.60% |
| BBIO | BridgeBio Pharma Inc | $13.00B | +9614734.80% |
| EXEL | Exelixis Inc | $12.69B | +9385390.34% |
| IONS | Ionis Pharmaceuticals Inc | $12.69B | +9383310.92% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.16B | +8990430.44% |
| AXSM | Axsome Therapeutics Inc | $12.06B | +8916925.35% |
| ARWR | Arrowhead Pharmaceuticals Inc | $11.10B | +8210447.79% |
| ABVX | Abivax | $10.29B | +7606133.06% |
| BMRN | Biomarin Pharmaceutical Inc | $10.12B | +7485587.39% |
| PRAX | Praxis Precision Medicines Inc | $9.95B | +7356957.58% |
| CYTK | Cytokinetics Inc | $9.51B | +7032374.74% |
| KRYS | Krystal Biotech Inc | $9.03B | +6674303.77% |
| NUVL | Nuvalent Inc - Class A | $8.45B | +6246430.76% |
| IBRX | ImmunityBio Inc | $8.26B | +6110297.37% |
| HALO | Halozyme Therapeutics Inc | $8.14B | +6016449.06% |
| TECH | Bio-Techne Corp | $7.53B | +5565577.72% |
| MTSR | Metsera Inc | $7.40B | +5475207.47% |
| PCVX | Vaxcyte Inc | $7.36B | +5444376.86% |
| CORT | Corcept Therapeutics Inc | $6.96B | +5146856.65% |
| MRUS | Merus N.V | $6.83B | +5047099.99% |
| IMVT | Immunovant Inc | $6.81B | +5038198.89% |
| KYMR | Kymera Therapeutics Inc | $6.71B | +4964720.84% |
| ACLX | Arcellx Inc | $6.67B | +4928968.64% |
| PTGX | Protagonist Therapeutics Inc | $6.56B | +4854077.98% |
| CELC | Celcuity Inc | $6.48B | +4789341.54% |
| RYTM | Rhythm Pharmaceuticals Inc | $6.26B | +4626774.96% |
| CNTA | Centessa Pharmaceuticals plc | $6.15B | +4550110.62% |
| SRRK | Scholar Rock Holding Corp | $6.03B | +4459783.41% |
| TGTX | TG Therapeutics Inc | $6.00B | +4437500.27% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +4397801.02% |
| MIRM | Mirum Pharmaceuticals Inc | $5.93B | +4384751.11% |
| COGT | Cogent Biosciences Inc | $5.89B | +4357732.11% |
| PTCT | PTC Therapeutics Inc | $5.86B | +4330402.23% |
| APGE | Apogee Therapeutics Inc | $5.82B | +4305011.61% |
| SYRE | Spyre Therapeutics Inc | $5.72B | +4227053.55% |
| BLTE | Belite Bio Inc | $5.59B | +4133245.54% |
| CGON | Cg Oncology Inc | $5.35B | +3956560.95% |
| LEGN | Legend Biotech Corp | $5.26B | +3892984.63% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +3880996.47% |
| XENE | Xenon Pharmaceuticals Inc | $5.21B | +3850945.20% |
| CRSP | CRISPR Therapeutics AG | $5.16B | +3815064.43% |
| DNTH | Dianthus Therapeutics Inc | $4.73B | +3497969.92% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $4.72B | +3493499.22% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +3330550.63% |
| TVTX | Travere Therapeutics Inc | $4.41B | +3263208.80% |
| AKRO | Akero Therapeutics Inc | $4.38B | +3238771.67% |
| CAI | Caris Life Sciences Inc - Class A | $4.35B | +3214379.95% |
| NAMS | NewAmsterdam Pharma Company NV | $4.26B | +3153191.71% |
| ERAS | Erasca Inc | $3.88B | +2865802.25% |
| CRNX | Crinetics Pharmaceuticals Inc | $3.87B | +2864870.68% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.83B | +2829537.54% |
| VKTX | Viking Therapeutics Inc | $3.67B | +2713063.30% |
| ACAD | Acadia Pharmaceuticals Inc | $3.63B | +2680612.47% |
| EWTX | Edgewise Therapeutics Inc | $3.60B | +2665537.88% |
| TLX | Telix Pharmaceuticals Ltd | $3.30B | +2439836.04% |
| BEAM | Beam Therapeutics Inc | $3.28B | +2422636.47% |
| DNLI | Denali Therapeutics Inc | $3.21B | +2370880.43% |
| RCUS | Arcus Biosciences Inc | $3.01B | +2224316.18% |
| DYN | Dyne Therapeutics Inc | $3.00B | +2218268.38% |
| ORKA | ARCA biopharma Inc | $2.91B | +2151100.64% |
| TNGX | Tango Therapeutics Inc | $2.83B | +2094587.66% |
| GPCR | Structure Therapeutics Inc | $2.81B | +2077793.06% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +2027139.51% |
| RLAY | Relay Therapeutics Inc | $2.73B | +2018793.67% |
| ALMS | Alumis Inc | $2.67B | +1972236.79% |
| IRON | Disc Medicine Inc | $2.66B | +1969897.58% |
| ARQT | Arcutis Biotherapeutics Inc | $2.64B | +1955457.40% |
| TARS | Tarsus Pharmaceuticals Inc | $2.58B | +1910515.36% |
| IDYA | Ideaya Biosciences Inc | $2.57B | +1902062.19% |
| ELVN | Enliven Therapeutics Inc | $2.52B | +1864359.82% |
| IMNM | Immunome Inc | $2.50B | +1850146.97% |
| MLYS | Mineralys Therapeutics Inc | $2.47B | +1829630.02% |
| VERA | Vera Therapeutics Inc - Class A | $2.45B | +1811166.04% |
| ETNB | 89bio Inc | $2.34B | +1732370.56% |
| RARE | Ultragenyx Pharmaceutical Inc | $2.30B | +1700053.07% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +1639404.41% |
| KOD | Kodiak Sciences Inc | $2.18B | +1612655.42% |
| CLDX | Celldex Therapeutics Inc | $2.11B | +1557836.83% |
| ZLAB | Zai Lab Ltd | $2.08B | +1534261.07% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.03B | +1502580.82% |
| MESO | Mesoblast Ltd | $2.02B | +1492210.21% |
| TYRA | Tyra Biosciences Inc | $1.97B | +1458530.90% |
| SION | Sionna Therapeutics Inc | $1.96B | +1447458.49% |
| STOK | Stoke Therapeutics Inc | $1.96B | +1447327.90% |
| NBTX | Nanobiotix | $1.94B | +1431974.11% |
| AAPG | Ascentage Pharma Group International | $1.93B | +1428964.37% |
| PHVS | Pharvaris NV | $1.92B | +1422990.78% |
| IOVA | Iovance Biotherapeutics Inc | $1.91B | +1415581.17% |
| GLPG | Galapagos NV | $1.90B | +1403559.08% |
| RAPP | Rapport Therapeutics Inc | $1.89B | +1396612.18% |
| OCUL | Ocular Therapeutix Inc | $1.87B | +1382198.37% |
| TRVI | Trevi Therapeutics Inc | $1.86B | +1371964.48% |
| ADMA | Adma Biologics Inc | $1.84B | +1360273.20% |
| NVAX | Novavax Inc | $1.82B | +1348233.35% |
| ZYME | Zymeworks BC Inc | $1.81B | +1339928.90% |
| NRIX | Nurix Therapeutics Inc | $1.81B | +1335624.66% |
| HRMY | Harmony Biosciences Holdings Inc | $1.78B | +1316107.93% |
| VRDN | Viridian Therapeutics Inc | $1.77B | +1307549.49% |
| SRPT | Sarepta Therapeutics Inc | $1.76B | +1302003.68% |
| VCEL | Vericel Corp | $1.75B | +1292528.46% |
| OCS | Oculis Holding AG | $1.74B | +1289624.40% |
| SNDX | Syndax Pharmaceuticals Inc | $1.74B | +1283827.30% |
| BHVN | Biohaven Ltd | $1.70B | +1256373.85% |
| AGIO | Agios Pharmaceuticals Inc | $1.70B | +1255731.14% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.68B | +1243710.57% |
| CAPR | Capricor Therapeutics Inc | $1.68B | +1242420.80% |
| ANAB | AnaptysBio Inc | $1.67B | +1238307.54% |
| PVLA | Palvella Therapeutics Inc | $1.66B | +1230410.35% |
| ABCL | AbCellera Biologics Inc | $1.65B | +1222541.18% |
| TSHA | Taysha Gene Therapies Inc | $1.65B | +1221341.90% |
| NUVB | Nuvation Bio Inc - Class A | $1.64B | +1214380.29% |
| INVA | Innoviva Inc | $1.63B | +1207683.62% |
| NTLA | Intellia Therapeutics Inc | $1.62B | +1196920.04% |
| NKTR | Nektar Therapeutics | $1.62B | +1196124.42% |
| GLUE | Monte Rosa Therapeutics Inc | $1.62B | +1195169.33% |
| QURE | uniQure N.V. | $1.59B | +1173059.86% |
| ATAI | ATAI Life Sciences N.V. | $1.58B | +1167650.81% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +1156683.13% |
| SLS | SELLAS Life Sciences Group Inc | $1.56B | +1150349.08% |
| PGEN | Precigen Inc | $1.55B | +1147521.40% |
| IMTX | Immatics N.V | $1.53B | +1133913.09% |
| ARDX | Ardelyx Inc | $1.52B | +1126681.36% |
| MBX | MBX Biosciences Inc | $1.52B | +1121298.54% |
| INBX | Inhibrx Biosciences Inc | $1.50B | +1112428.24% |
| VIR | Vir Biotechnology Inc | $1.47B | +1084831.86% |
| IMCR | Immunocore Holdings plc | $1.45B | +1071889.15% |
| URGN | UroGen Pharma Ltd | $1.43B | +1056277.50% |
| BCAX | Bicara Therapeutics Inc | $1.41B | +1045844.86% |
| GHRS | GH Research PLC | $1.39B | +1025566.30% |
| KALV | KalVista Pharmaceuticals Inc | $1.37B | +1014897.58% |
| SEPN | Septerna Inc | $1.34B | +989321.61% |
| MPLT | MapLight Therapeutics Inc | $1.34B | +987738.44% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.31B | +970157.65% |
| MAZE | Maze Therapeutics Inc | $1.30B | +957969.48% |
| FTRE | FORTE SOFTWARE INC | $1.27B | +938645.65% |
| AVBP | ArriVent BioPharma Inc | $1.24B | +920236.95% |
| TRML | Tourmaline Bio Inc | $1.24B | +913647.25% |
| WVE | Wave Life Sciences Ltd | $1.22B | +901590.84% |
| ZBIO | Zenas Biopharma Inc | $1.13B | +834371.93% |
| OLMA | Olema Pharmaceuticals Inc | $1.13B | +833598.01% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.10B | +811986.21% |
| MNKD | Mannkind Corp | $1.10B | +810787.96% |
| DBVT | DBV Technologies | $1.10B | +809853.33% |
| CRVS | Corvus Pharmaceuticals Inc | $1.09B | +803887.60% |
| SVRA | Savara Inc | $1.07B | +789361.38% |
| JBIO | Jade Biosciences Inc | $1.06B | +784402.64% |
| CVAC | CureVac N.V. | $1.05B | +775800.84% |
| ANNX | Annexon Inc | $1.05B | +773902.74% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +738393.89% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +731849.52% |
| CGEM | Cullinan Oncology Inc | $953.73M | +705124.91% |
| PHAR | Pharming Group N.V. | $940.58M | +695406.67% |
| LXRX | Lexicon Pharmaceuticals Inc | $923.79M | +682987.35% |
| ABUS | Arbutus Biopharma Corp | $913.84M | +675630.16% |
| KURA | Kura Oncology Inc | $908.93M | +672003.59% |
| DRTS | Alpha Tau Medical Ltd | $905.62M | +669553.87% |
| ORIC | ORIC Pharmaceuticals Inc | $887.91M | +656460.73% |
| JANX | Janux Therapeutics Inc | $878.90M | +649793.77% |
| XNCR | Xencor Inc | $868.03M | +641758.15% |
| PHAT | Phathom Pharmaceuticals Inc | $853.21M | +630800.31% |
| SPRY | ARS Pharmaceuticals Inc | $844.05M | +624027.13% |
| GERN | Geron Corp | $843.41M | +623554.87% |
| EVMN | Evommune Inc | $841.03M | +621792.40% |
| VOR | Vor Biopharma Inc | $840.96M | +621741.56% |
| TBPH | Theravance Biopharma Inc | $837.63M | +619281.93% |
| DRUG | Bright Minds Biosciences Inc | $834.70M | +617112.37% |
| SANA | Sana Biotechnology Inc | $825.64M | +610413.15% |
| MGTX | MeiraGTx Holdings plc | $805.50M | +595522.38% |
| LBRX | LB Pharmaceuticals Inc | $797.16M | +589353.96% |
| OMER | Omeros Corporation | $797.02M | +589253.89% |
| ABSI | Absci Corp | $789.28M | +583529.51% |
| CMRX | Chimerix Inc | $766.03M | +566335.05% |
| RLMD | Relmada Therapeutics Inc | $761.50M | +562987.54% |
| ANRO | Alto Neuroscience Inc | $714.55M | +528268.43% |
| ATXS | Astria Therapeutics Inc | $709.95M | +524867.77% |
| DSGN | Design Therapeutics Inc | $693.10M | +512407.35% |
| SLDB | Solid Biosciences Inc | $690.73M | +510655.66% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $683.16M | +505056.35% |
| CTMX | CytomX Therapeutics Inc | $675.41M | +499326.81% |
| CRMD | CorMedix Inc | $663.22M | +490316.04% |
| IVA | Inventiva | $655.21M | +484393.39% |
| ZVRA | Zevra Therapeutics Inc | $647.31M | +478546.62% |
| CABA | Cabaletta Bio Inc | $640.38M | +473427.33% |
| ACRS | Aclaris Therapeutics Inc | $639.61M | +472854.72% |
| PRME | Prime Medicine Inc | $596.03M | +440630.67% |
| CADL | Candel Therapeutics Inc | $589.73M | +435968.20% |
| CBIO | Crescent Biopharma Inc | $573.22M | +423763.50% |
| TECX | AvroBio Inc | $573.01M | +423607.95% |
| CLYM | Eliem Therapeutics Inc | $571.31M | +422352.09% |
| ARVN | Arvinas Inc | $570.83M | +421992.15% |
| ALLO | Allogene Therapeutics Inc | $550.84M | +407212.12% |
| VALN | Valneva SE | $545.52M | +403282.55% |
| RIGL | Rigel Pharmaceuticals | $542.79M | +401258.75% |
| GYRE | Gyre Therapeutics Inc | $540.72M | +399728.10% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $538.30M | +397940.81% |
| MDXG | Mimedx Group Inc | $537.64M | +397455.39% |
| PRTA | Prothena Corporation plc | $532.36M | +393552.87% |
| KYTX | Kyverna Therapeutics Inc | $519.97M | +384390.89% |
| CTNM | Contineum Therapeutics Inc - Class A | $501.84M | +370979.14% |
| XOMA | XOMA Corp | $497.12M | +367489.56% |
| STRO | Sutro Biopharma Inc | $491.87M | +363608.28% |
| OCGN | Ocugen Inc | $466.88M | +345130.88% |
| SVA | Sinovac Biotech Ltd | $464.94M | +343695.37% |
| IMMX | Immix Biopharma Inc | $462.80M | +342110.61% |
| FDMT | 4D Molecular Therapeutics Inc | $462.60M | +341969.02% |
| STTK | Shattuck Labs Inc | $458.03M | +338583.52% |
| FULC | Fulcrum Therapeutics Inc | $451.60M | +333834.28% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +333692.35% |
| UPB | Upstream Bio Inc | $449.51M | +332286.03% |
| AUTL | Autolus Therapeutics plc | $447.12M | +330520.14% |
| ADCT | Adc Therapeutics SA | $438.08M | +323837.71% |
| ASMB | Assembly Biosciences Inc | $435.45M | +321890.49% |
| MNPR | Monopar Therapeutics Inc | $432.42M | +319652.93% |
| AURA | Aura Biosciences Inc | $430.49M | +318221.96% |
| OVID | Ovid Therapeutics Inc | $424.86M | +314057.10% |
| NGNE | Neoleukin Therapeutics Inc | $419.60M | +310167.15% |
| IPSC | Century Therapeutics Inc | $415.14M | +306869.04% |
| ZURA | Zura Bio Ltd - Class A | $408.94M | +302284.47% |
| CMPX | Compass Therapeutics Inc | $408.80M | +302183.83% |
| CYBN | Cybin Inc | $408.43M | +301911.89% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +298459.61% |
| GLSI | Greenwich LifeSciences Inc | $403.22M | +298054.58% |
| BNTC | Benitec Biopharma Inc | $398.51M | +294575.35% |
| LYEL | Lyell Immunopharma Inc | $390.28M | +288492.47% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +288421.67% |
| CCCC | C4 Therapeutics Inc | $389.10M | +287614.00% |
| VNDA | Vanda Pharmaceuticals Inc | $388.47M | +287153.00% |
| ENTA | Enanta Pharmaceuticals Inc | $383.31M | +283339.02% |
| RVNC | Revance Therapeutics Inc | $380.38M | +281166.88% |
| XFOR | X4 Pharmaceuticals Inc | $380.11M | +280968.21% |
| LXEO | Lexeo Therapeutics Inc | $377.10M | +278744.79% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +278657.72% |
| OABI | OmniAb Inc | $374.99M | +277183.52% |
| REPL | Replimune Group Inc | $374.27M | +276648.47% |
| ALT | Altimmune Inc | $373.67M | +276210.96% |
| VSTM | Verastem Inc | $373.33M | +275958.02% |
| EPRX | Eupraxia Pharmaceuticals Inc | $372.92M | +275655.41% |
| PBYI | Puma Biotechnology Inc | $371.93M | +274918.54% |
| LRMR | Larimar Therapeutics Inc | $365.67M | +270290.34% |
| CLLS | Cellectis | $364.91M | +269732.85% |
| AVIR | Atea Pharmaceuticals Inc | $364.12M | +269148.17% |
| EDIT | Editas Medicine Inc | $349.39M | +258250.17% |
| PALI | Palisade Bio Inc | $346.56M | +256163.28% |
| RGNX | Regenxbio Inc | $345.32M | +255242.53% |
| IMRX | Immuneering Corp Class A | $344.95M | +254974.13% |
| FENC | Fennec Pharmaceuticals Inc | $344.37M | +254544.53% |
| PRLD | Prelude Therapeutics Inc | $343.28M | +253738.06% |
| FBRX | Forte Biosciences Inc | $340.15M | +251422.81% |
| IMAB | I-Mab | $339.64M | +251041.27% |
| NMRA | Neumora Therapeutics Inc | $334.56M | +247289.23% |
| DMAC | DiaMedica Therapeutics Inc | $328.69M | +242946.11% |
| LCTX | Lineage Cell Therapeutics Inc | $326.58M | +241387.63% |
| RCKT | Rocket Pharmaceuticals Inc | $326.28M | +241165.07% |
| NAUT | Nautilus Biotechnology Inc | $325.30M | +240440.89% |
| ABEO | Abeona Therapeutics Inc | $323.57M | +239161.13% |
| SLN | Silence Therapeutics Plc | $321.20M | +237405.44% |
| RZLT | Rezolute Inc | $319.69M | +236292.70% |
| IVVD | Invivyd Inc | $319.57M | +236202.36% |
| BCYC | Bicycle Therapeutics Plc | $318.56M | +235457.56% |
| ANL | Adlai Nortye Ltd | $317.46M | +234639.96% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +225474.32% |
| SCPH | scPharmaceuticals Inc | $304.59M | +225127.08% |
| NAGE | Niagen Bioscience Inc | $304.32M | +224927.31% |
| SRZN | Surrozen Inc | $304.03M | +224709.24% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +223848.87% |
| ELDN | Eledon Pharmaceuticals Inc | $295.82M | +218643.09% |
| IRD | Ocuphire Pharma Inc | $295.61M | +218483.75% |
| ARMP | Armata Pharmaceuticals Inc | $289.32M | +213835.33% |
| ACIU | AC Immune SA | $289.11M | +213682.28% |
| TENX | Tenax Therapeutics Inc | $288.39M | +213149.94% |
| ZNTL | Zentalis Pharmaceuticals Inc | $286.05M | +211415.67% |
| YDES | YD Bio Ltd | $278.91M | +206137.62% |
| MGNX | Macrogenics Inc | $278.39M | +205755.63% |
| FATE | Fate Therapeutics Inc | $275.57M | +203665.05% |
| CNTX | Context Therapeutics Inc | $273.80M | +202359.26% |
| SABS | SAB Biotherapeutics Inc | $272.68M | +201531.47% |
| NVCT | Nuvectis Pharma Inc | $269.23M | +198983.12% |
| ALXO | Alx Oncology Holdings Inc | $263.70M | +194890.82% |
| TARA | Protara Therapeutics Inc | $262.06M | +193681.63% |
| CGEN | Compugen Ltd | $260.97M | +192869.89% |
| TRDA | Entrada Therapeutics Inc | $257.38M | +190218.16% |
| CHRS | Coherus Biosciences Inc | $256.00M | +189198.14% |
| AVXL | Anavex Life Sciences Corporation | $255.77M | +189030.15% |
| HUMA | Humacyte Inc | $255.32M | +188695.87% |
| FHTX | Foghorn Therapeutics Inc | $250.69M | +185273.59% |
| ALEC | Alector Inc | $245.37M | +181333.75% |
| LENZ | LENZ Therapeutics Inc | $242.37M | +179118.23% |
| THRD | Third Harmonic Bio Inc | $241.86M | +178744.88% |
| CDXS | Codexis Inc | $239.96M | +177336.69% |
| VYGR | Voyager Therapeutics Inc | $237.02M | +175162.88% |
| ADAG | Adagene Inc | $236.93M | +175094.56% |
| NKTX | Nkarta Inc | $236.88M | +175061.26% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +172198.87% |
| OBIO | Orchestra BioMed Holdings Inc | $231.59M | +171148.42% |
| NERV | Minerva Neurosciences Inc | $230.61M | +170421.98% |
| SLRN | Acelyrin Inc | $228.54M | +168895.32% |
| WHWK | Whitehawk Therapeutics Inc | $225.60M | +166717.87% |
| IKT | Inhibikase Therapeutics Inc | $224.46M | +165871.88% |
| CRBU | Caribou Biosciences Inc | $223.96M | +165503.54% |
| KROS | Keros Therapeutics Inc | $223.18M | +164927.54% |
| RNA | Atrium Therapeutics Inc | $222.37M | +164332.27% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +161547.72% |
| ARCT | Arcturus Therapeutics Holdings Inc | $217.72M | +160891.51% |
| SLGL | Sol-Gel Technologies Ltd | $205.59M | +151922.74% |
| KPTI | Karyopharm Therapeutics Inc | $202.45M | +149596.48% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +149123.90% |
| ELTX | Elicio Therapeutics Inc | $200.75M | +148344.27% |
| KRRO | Korro Bio Inc | $198.45M | +146645.71% |
| RNAC | Cartesian Therapeutics Inc | $197.81M | +146172.75% |
| DTIL | Precision Biosciences Inc | $195.87M | +144732.17% |
| IMUX | Immunic Inc | $190.70M | +140912.21% |
| QTTB | Q32 Bio Inc | $187.99M | +138906.72% |
| ENLV | Enlivex Therapeutics Ltd | $185.63M | +137164.40% |
| MDWD | MediWound Ltd | $184.49M | +136316.24% |
| ABOS | Acumen Pharmaceuticals Inc | $183.46M | +135556.64% |
| THAR | Tharimmune Inc | $183.00M | +135217.76% |
| IFRX | InflaRx N.V. | $182.18M | +134610.12% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +133599.66% |
| UNCY | Unicycive Therapeutics Inc | $178.43M | +131839.52% |
| GALT | Galectin Therapeutics Inc | $177.81M | +131382.91% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +128224.89% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $172.60M | +127527.15% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $172.60M | +127524.50% |
| HRTX | Heron Therapeutics Inc | $172.54M | +127483.32% |
| TNYA | Tenaya Therapeutics Inc | $171.88M | +126998.90% |
| RANI | Rani Therapeutics Holdings Inc Class A | $171.00M | +126341.82% |
| SPRO | Spero Therapeutics Inc | $169.62M | +125325.74% |
| PLX | Protalix BioTherapeutics Inc | $169.28M | +125072.53% |
| THTX | Theratechnologies Inc | $167.34M | +123635.77% |
| ANTX | AN2 Therapeutics Inc | $166.61M | +123100.94% |
| EQ | Equillium Inc | $166.29M | +122858.78% |
| MIST | Milestone Pharmaceuticals Inc | $164.91M | +121843.04% |
| PRQR | ProQR Therapeutics N.V | $164.37M | +121438.49% |
| MENS | Jyong Biotech Ltd | $164.22M | +121331.57% |
| ORMP | Oramed Pharmaceuticals Inc | $162.89M | +120344.65% |
| IPHA | Innate Pharma | $159.97M | +118189.32% |
| TTRX | Turn Therapeutics Inc | $157.58M | +116420.38% |
| MOLN | Molecular Partners AG | $154.89M | +114428.92% |
| VXRT | Vaxart Inc | $153.61M | +113487.03% |
| HURA | TuHURA Biosciences Inc | $151.32M | +111790.11% |
| NBP | NovaBridge Biosciences. | $150.91M | +111490.70% |
| CNTB | Connect Biopharma Holdings Ltd | $150.51M | +111192.02% |
| AKTX | Akari Therapeutics Plc | $148.12M | +109429.50% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +107382.65% |
| INDP | Indaptus Therapeutics Inc | $143.82M | +106244.93% |
| NRXP | NRX Pharmaceuticals Inc | $143.26M | +105830.45% |
| PROK | ProKidney Corp - Class A | $137.85M | +101832.21% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +101666.55% |
| GNLX | Genelux Corp | $137.21M | +101360.11% |
| GUTS | Fractyl Health Inc | $136.31M | +100694.26% |
| BDTX | Black Diamond Therapeutics Inc | $132.37M | +97777.83% |
| AGEN | Agenus Inc | $131.36M | +97032.55% |
| ACOG | Alpha Cognition Inc | $124.77M | +92156.97% |
| CRDF | Cardiff Oncology Inc | $123.75M | +91405.76% |
| KLRS | Kalaris Therapeutics Inc | $120.48M | +88987.71% |
| NTHI | NeOnc Technologies Holdings Inc | $120.03M | +88655.18% |
| SEER | Seer Inc - Class A | $115.64M | +85410.70% |
| ENGN | enGene Holdings Inc | $115.22M | +85099.93% |
| RPTX | Repare Therapeutics Inc | $113.91M | +84131.54% |
| COYA | Coya Therapeutics Inc | $111.89M | +82636.76% |
| PYXS | Pyxis Oncology Inc | $108.70M | +80275.94% |
| VANI | Vivani Medical Inc | $108.35M | +80018.16% |
| CGTX | Cognition Therapeutics Inc | $106.33M | +78525.63% |
| HLVX | HilleVax Inc | $104.74M | +77348.37% |
| ONCY | Oncolytics Biotech Inc | $104.52M | +77183.07% |
| VRCA | Verrica Pharmaceuticals Inc | $104.10M | +76878.49% |
| ALDX | Aldeyra Therapeutics Inc | $103.15M | +76172.75% |
| PEPG | PepGen Inc | $103.13M | +76157.31% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +75621.35% |
| BMEA | Biomea Fusion Inc | $98.33M | +72607.32% |
| CBUS | Cibus Global Ltd. Class A | $97.80M | +72219.94% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +72173.38% |
| ICCC | Immucell Corp | $96.17M | +71010.30% |
| PMN | ProMIS Neurosciences Inc | $93.94M | +69360.68% |
| ATHA | Athira Pharma Inc | $92.15M | +68039.88% |
| FBIO | Fortress Biotech Inc | $91.60M | +67629.37% |
| PTHS | Channel Therapeutics Corporation | $90.85M | +67080.40% |
| ATRA | Atara Biotherapeutics Inc | $89.72M | +66240.16% |
| ANIX | Anixa Biosciences Inc | $88.68M | +65472.35% |
| EXOZ | Invizyne Technologies Inc | $88.10M | +65042.45% |
| INO | Inovio Pharmaceuticals Inc | $87.22M | +64391.60% |
| AARD | Aardvark Therapeutics Inc | $87.05M | +64266.51% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +64224.31% |
| PYPD | Polypid Ltd | $86.83M | +64108.06% |
| NRXS | Neuraxis Inc | $85.30M | +62976.52% |
| LPTX | Leap Therapeutics Inc | $84.76M | +62574.22% |
| CSBR | Champions Oncology Inc | $82.35M | +60792.24% |
| ACET | Adicet Bio Inc | $81.58M | +60223.99% |
| HYFT | MindWalk Holdings Corp | $79.54M | +58716.55% |
| MAIA | MAIA Biotechnology Inc | $79.48M | +58670.62% |
| SGMO | Sangamo Therapeutics Inc | $77.92M | +57519.71% |
| FBIOP | Fortress Biotech Inc | $77.72M | +57369.55% |
| RLYB | Rallybio Corp | $76.87M | +56738.81% |
| PLRX | Pliant Therapeutics Inc | $76.77M | +56669.99% |
| GANX | Gain Therapeutics Inc | $75.20M | +55509.60% |
| LIXT | Lixte Biotechnology Holdings Inc | $74.68M | +55124.14% |
| XBIT | XBiotech Inc | $74.39M | +54907.16% |
| OSTX | OS Therapies Inc | $74.24M | +54793.08% |
| MCRB | Seres Therapeutics Inc | $73.19M | +54019.37% |
| SAVA | Cassava Sciences Inc. | $72.46M | +53481.35% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +53085.10% |
| EDSA | Edesa Biotech Inc | $70.82M | +52266.70% |
| BYSI | BeyondSpring Inc | $70.31M | +51893.80% |
| ATHE | Alterity Therapeutics Ltd | $68.71M | +50709.18% |
| SPRB | Spruce Biosciences Inc | $67.96M | +50148.95% |
| CUE | Cue Biopharma Inc | $66.52M | +49090.11% |
| IMA | Ikena Oncology Inc | $66.48M | +49060.21% |
| MNOV | Medicinova Inc | $65.46M | +48307.04% |
| IBIO | iBio Inc | $64.94M | +47920.78% |
| ACRV | Acrivon Therapeutics Inc | $64.32M | +47458.53% |
| PMVP | PMV Pharmaceuticals Inc | $64.00M | +47222.92% |
| IMMP | Immutep Ltd | $63.92M | +47166.21% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +46894.00% |
| OKYO | OKYO Pharma Ltd - New | $63.24M | +46663.84% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +46647.54% |
| PDSB | PDS Biotechnology Corporation | $61.96M | +45712.42% |
| OTLK | Outlook Therapeutics Inc | $61.25M | +45192.04% |
| GLTO | Galecto Inc | $60.81M | +44865.31% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +43674.77% |
| ANVS | Annovis Bio Inc | $57.22M | +42208.88% |
| DWTX | Virios Therapeutics Inc | $57.12M | +42134.47% |
| ENTX | Entera Bio Ltd | $55.48M | +40924.60% |
| TIL | Instil Bio Inc | $55.21M | +40721.12% |
| KZR | Kezar Life Sciences Inc | $53.76M | +39651.82% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | $52.83M | +38966.51% |
| MREO | Mereo Biopharma Group Plc | $52.71M | +38876.52% |
| NBY | Stablecoin Development Corp | $52.10M | +38423.58% |
| RNTX | Rein Therapeutics Inc | $51.79M | +38198.98% |
| GOSS | Gossamer Bio Inc | $51.14M | +37715.32% |
| MGX | Metagenomi Inc | $50.82M | +37481.07% |
| ACTU | Actuate Therapeutics Inc | $50.03M | +36895.51% |
| INKT | MiNK Therapeutics Inc | $48.84M | +36015.80% |
| ESLA | Estrella Immunopharma Inc | $48.44M | +35718.02% |
| XLO | Xilio Therapeutics Inc | $48.23M | +35560.60% |
| CING | Cingulate Inc | $47.16M | +34769.83% |
| ATYR | Atyr Pharma Inc | $46.89M | +34571.04% |
| LVTX | LAVA Therapeutics NV | $45.77M | +33745.17% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +33712.25% |
| PSTV | Plus Therapeutics Inc | $45.56M | +33591.84% |
| ATOS | Atossa Therapeutics Inc | $44.09M | +32502.14% |
| KALA | Kala Bio Inc | $43.31M | +31928.43% |
| RNXT | RenovoRx Inc | $41.96M | +30925.21% |
| NTRB | Nutriband Inc | $41.39M | +30506.35% |
| HYPD | Eyenovia Inc | $41.14M | +30322.53% |
| FGEN | FibroGen Inc | $39.31M | +28964.58% |
| NNVC | NanoViricides Inc | $37.88M | +27911.45% |
| VERU | Veru Inc | $37.40M | +27553.10% |
| LTRN | Lantern Pharma Inc | $37.25M | +27446.48% |
| INMB | INmune Bio Inc | $37.22M | +27421.57% |
| ATNM | Actinium Pharmaceuticals Inc | $36.71M | +27043.99% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +26597.49% |
| GRCE | Acasti Pharma Inc | $36.05M | +26560.21% |
| GBIO | Generation Bio Company | $35.97M | +26496.64% |
| ABVC | ABVC BioPharma Inc | $35.82M | +26384.64% |
| MURA | Mural Oncology plc | $35.34M | +26033.76% |
| LITS | Lite Strategy Inc | $35.16M | +25895.83% |
| ALGS | Aligos Therapeutics Inc | $34.65M | +25524.52% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $34.30M | +25262.46% |
| DARE | Dare Bioscience Inc | $33.92M | +24984.57% |
| EVAX | Evaxion Biotech A/S | $33.82M | +24907.62% |
| BOLD | Boundless Bio Inc | $32.94M | +24255.96% |
| SNTI | Senti Biosciences Inc | $31.46M | +23160.05% |
| TVRD | Cara Therapeutics Inc | $30.96M | +22791.98% |
| LSTA | Lisata Therapeutics Inc | $30.05M | +22123.24% |
| TVGN | Tevogen Bio Holdings Inc | $29.97M | +22063.30% |
| APLM | Apollomics Inc - Class A | $29.93M | +22031.98% |
| NRSN | NeuroSense Therapeutics Ltd | $29.15M | +21453.59% |
| SKYE | Skye Bioscience Inc | $29.10M | +21419.71% |
| NEUP | Neuphoria Therapeutics Inc | $29.04M | +21371.61% |
| GRDX | Entero Therapeutics Inc | $28.95M | +21309.20% |
| BRNS | Barinthus Biotherapeutics Plc. | $28.59M | +21037.74% |
| CRVO | CervoMed Inc | $28.15M | +20712.72% |
| IGC | IGC Pharma Inc | $28.00M | +20603.51% |
| DYAI | Dyadic International Inc DE | $27.40M | +20159.43% |
| ALLR | Allarity Therapeutics Inc | $27.37M | +20136.20% |
| SER | AgeX Therapeutics Inc | $26.82M | +19730.51% |
| PLRZ | Polyrizon Ltd | $26.52M | +19510.24% |
| CELU | Celularity Inc - Class A | $26.39M | +19413.48% |
| VTGN | VistaGen Therapeutics Inc | $26.36M | +19390.58% |
| BCTX | BriaCell Therapeutics Corp - New | $26.32M | +19361.58% |
| PTN | Palatin Technologies Inc | $26.08M | +19181.49% |
| TPST | Tempest Therapeutics Inc | $25.68M | +18885.79% |
| JSPR | Jasper Therapeutics Inc | $25.26M | +18581.51% |
| PLUR | Pluri Inc | $24.62M | +18102.60% |
| MRKR | Marker Therapeutics Inc | $24.21M | +17805.60% |
| HOWL | Werewolf Therapeutics Inc | $23.81M | +17507.93% |
| VYNE | VYNE Therapeutics Inc | $22.68M | +16668.04% |
| SNSE | Sensei Biotherapeutics Inc | $22.32M | +16401.80% |
| HOTH | Hoth Therapeutics Inc | $22.13M | +16262.29% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | +16135.11% |
| NXTC | Nextcure Inc | $21.90M | +16092.20% |
| OPT | Opthea Ltd | $21.53M | +15819.79% |
| CRIS | Curis Inc | $21.11M | +15508.70% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | +14967.10% |
| LGVN | Longeveron Inc - Class A | $19.70M | +14468.95% |
| GNTA | Genenta Science SpA | $19.23M | +14116.60% |
| AEON | AEON Biopharma Inc - Class A | $19.22M | +14114.10% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $18.90M | +13874.70% |
| XCUR | Exicure Inc | $17.78M | +13049.62% |
| INAB | IN8bio Inc | $17.72M | +13006.44% |
| PASG | Passage Bio Inc | $17.71M | +12993.39% |
| KTTA | Pasithea Therapeutics Corp | $17.28M | +12678.22% |
| MTVA | MetaVia Inc | $17.25M | +12654.64% |
| LPCN | Lipocine Inc | $17.04M | +12502.51% |
| NCEL | NLS Pharmaceutics Ltd | $16.55M | +12138.80% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $16.12M | +11817.65% |
| HIND | ReShape Lifesciences Inc | $15.72M | +11525.14% |
| COCP | Cocrystal Pharma Inc | $15.44M | +11318.05% |
| CTXR | Citius Pharmaceuticals Inc | $15.44M | +11316.79% |
| LEXX | Lexaria Bioscience Corp | $15.24M | +11168.05% |
| CLRB | Cellectar Biosciences Inc | $14.97M | +10967.72% |
| QNCX | Quince Therapeutics Inc | $14.89M | +10913.30% |
| APLT | Applied Therapeutics Inc | $14.86M | +10890.31% |
| HOOK | Hookipa Pharma Inc | $14.68M | +10753.08% |
| BLRX | Bioline Rx Ltd | $14.66M | +10743.24% |
| MBRX | Moleculin Biotech Inc | $14.57M | +10672.37% |
| IOBT | IO Biotech Inc | $14.50M | +10620.63% |
| ICU | SeaStar Medical Holding Corp | $14.34M | +10501.72% |
| GDTC | CytoMed Therapeutics Ltd | $14.15M | +10360.51% |
| GTBP | GT Biopharma Inc | $13.91M | +10183.72% |
| CMMB | Chemomab Therapeutics Ltd | $13.67M | +10004.71% |
| TOVX | Theriva Biologics Inc | $13.51M | +9887.06% |
| CYCN | Cyclerion Therapeutics Inc | $13.36M | +9778.93% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | +9527.99% |
| ERNA | Ernexa Therapeutics Inc | $12.99M | +9504.79% |
| PHIO | Phio Pharmaceuticals Corp | $12.78M | +9349.31% |
| CVKD | Cadrenal Therapeutics Inc | $12.33M | +9019.94% |
| CALC | CalciMedica Inc | $11.72M | +8569.80% |
| LNAI | Lunai Bioworks Inc | $11.72M | +8563.00% |
| TRAW | Traws Pharma Inc | $11.70M | +8549.57% |
| INTS | Intensity Therapeutics Inc | $11.33M | +8278.41% |
| BIVI | BioVie Inc - Class A | $11.16M | +8153.60% |
| KPRX | Kiora Pharmaceuticals Inc | $11.14M | +8138.70% |
| BRTX | BioRestorative Therapies Inc | $11.03M | +8055.68% |
| APRE | Aprea Therapeutics Inc | $10.96M | +8003.88% |
| KAPA | Kairos Pharma Ltd | $10.68M | +7800.34% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | +7609.81% |
| CVM | Cel-Sci Corp | $10.15M | +7402.11% |
| BOLT | Bolt Biotherapeutics Inc | $10.13M | +7388.08% |
| MLEC | Moolec Science SA | $10.06M | +7336.79% |
| BCDA | BioCardia Inc | $9.85M | +7183.22% |
| QNRX | Quoin Pharmaceuticals Ltd | $9.81M | +7150.99% |
| CURX | Curanex Pharmaceuticals Inc | $9.73M | +7094.13% |
| SNGX | Soligenix Inc | $9.11M | +6633.11% |
| IMNN | Imunon Inc | $9.02M | +6571.51% |
| EPIX | Essa Pharma Inc | $8.93M | +6503.94% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | +6493.95% |
| CANF | Can-Fite Biopharma Ltd | $8.80M | +6405.55% |
| JUNS | Jupiter Neurosciences Inc | $8.70M | +6336.03% |
| CELZ | Creative Medical Technology Holdings Inc | $8.54M | +6214.32% |
| IMRN | Immuron Ltd | $8.36M | +6080.14% |
| PMCB | PharmaCyte Biotech Inc | $8.16M | +5933.18% |
| LIMN | Liminatus Pharma Inc | $8.08M | +5873.20% |
| ITRM | Iterum Therapeutics Plc | $8.06M | +5860.75% |
| NCNA | NuCana plc | $7.95M | +5777.28% |
| ADXN | Addex Therapeutics Ltd | $7.90M | +5740.68% |
| SYBX | Synlogic Inc | $7.72M | +5609.45% |
| BCLI | Brainstorm Cell Therapeutics Inc | $7.66M | +5567.64% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | +5324.45% |
| XBIO | Xenetic Biosciences Inc | $7.06M | +5123.99% |
| GNPX | Genprex Inc | $7.02M | +5092.01% |
| ASBP | Aspire Biopharma Holdings Inc | $6.98M | +5062.38% |
| EVGN | Evogene Ltd | $6.91M | +5012.72% |
| SILO | SILO Pharma Inc | $6.78M | +4915.76% |
| ACXP | Acurx Pharmaceuticals Inc | $6.74M | +4887.04% |
| TCRT | Alaunos Therapeutics Inc | $6.68M | +4841.88% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | +4632.45% |
| GOVX | Geovax Labs Inc | $6.29M | +4547.70% |
| APM | Aptorum Group Ltd - Class A | $6.26M | +4525.68% |
| BCAB | BioAtla Inc | $6.19M | +4477.41% |
| PPBT | Purple Biotech Ltd | $6.05M | +4373.30% |
| APVO | Aptevo Therapeutics Inc | $5.83M | +4208.11% |
| BGMS | Bio Green Med Solution Inc | $5.30M | +3818.07% |
| CLGN | CollPlant Biotechnologies Ltd New | $5.25M | +3782.45% |
| DRMA | Dermata Therapeutics Inc | $5.23M | +3766.39% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.18M | +3729.62% |
| HCWB | HCW Biologics Inc | $5.10M | +3669.24% |
| PULM | Pulmatrix Inc | $4.97M | +3572.89% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | +3530.40% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $4.91M | +3527.03% |
| MTNB | Matinas Biopharma Holdings Inc | $4.68M | +3360.38% |
| RNAZ | TransCode Therapeutics Inc | $4.67M | +3351.25% |
| ALZN | Alzamend Neuro Inc | $4.38M | +3135.39% |
| MBIO | Mustang Bio Inc | $4.29M | +3072.42% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | +3053.98% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | +3052.92% |
| REVB | Revelation Biosciences Inc | $4.26M | +3050.16% |
| FBLG | FibroBiologics Inc | $4.23M | +3024.65% |
| ENVB | Enveric Biosciences Inc | $4.15M | +2970.59% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | +2960.10% |
| GLMD | Galmed Pharmaceuticals Ltd | $4.08M | +2917.27% |
| PHGE | BiomX Inc | $3.91M | +2788.21% |
| PBM | Psyence Biomedical Ltd | $3.76M | +2682.58% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $3.72M | +2649.15% |
| ADIL | Adial Pharmaceuticals Inc | $3.61M | +2567.16% |
| VIVS | VivoSim Labs Inc | $3.36M | +2387.68% |
| XRTX | XORTX Therapeutics Inc | $3.34M | +2371.12% |
| AZTR | Azitra Inc | $3.32M | +2355.74% |
| GRI | GRI Bio Inc | $3.30M | +2337.69% |
| SPRC | SciSparc Ltd | $3.05M | +2152.01% |
| AFMD | Affimed N.V. | $2.98M | +2099.99% |
| CMND | Clearmind Medicine Inc | $2.88M | +2031.07% |
| ENSC | Ensysce Biosciences Inc | $2.88M | +2026.73% |
| ARTL | Artelo Biosciences Inc | $2.75M | +1930.62% |
| OGEN | Oragenics Inc | $2.58M | +1805.77% |
| PPCB | Propanc Biopharma Inc | $2.50M | +1749.82% |
| NTBL | Notable Labs Inc Ord | $2.39M | +1670.67% |
| BBLG | Bone Biologics Corp | $2.23M | +1546.09% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | +1486.79% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | +1443.96% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | +1374.68% |
| AIM | AIM ImmunoTech Inc. | $1.74M | +1189.78% |
| ONCO | Onconetix Inc | $1.61M | +1091.81% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | +1052.60% |
| ZVSA | ZyVersa Therapeutics Inc | $1.55M | +1049.40% |
| SCNI | Scinai Immunotherapeutics Ltd | $1.55M | +1048.66% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | +1023.51% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | +955.01% |
| LYRA | Lyra Therapeutics Inc | $1.38M | +923.69% |
| JAGX | Jaguar Health Inc | $1.34M | +893.48% |
| SLXN | Silexion Therapeutics Corp | $1.30M | +862.48% |
| PTIX | Protagenic Therapeutics Inc | $1.01M | +645.12% |
| BDRX | Biodexa Pharmaceuticals Plc | $919907.57 | +580.22% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | +307.46% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | +230.42% |
| ELAB | PMGC Holdings Inc | $221376.00 | +63.69% |
| ADTX | Aditxt Inc | $132564.52 | -1.98% |